{"pageContent": "Background: The outcomes of metastatic hormone-sensitive prostate cancer (mHSPC) have significantly improved through treatment intensification, yet Black representation in those studies is suboptimal.", "metaData": {"source": "Prostate cancer 2004: insights from national disease registries\nhttps://pubmed.ncbi.nlm.nih.gov/15526829/"}}